Literature DB >> 8940628

Expression of the rat brain creatine transporter in situ and in transfected HeLa cells.

M D Saltarelli1, A L Bauman, K R Moore, C C Bradley, R D Blakely.   

Abstract

Using degenerate oligonucleotide probes encoding conserved regions of the gamma-aminobutyric acid/norepinephrine transporter gene family, we have cloned a rat brain cDNA encoding a creatine transporter (rCREAT). rCREAT encodes a highly hydrophobic, 635-amino-acid protein possessing 12 potential transmembrane domains and canonical sites for N-linked glycosylation and protein phosphorylation. Transfection of rCREAT cDNA into mammalian cells results in the expression of [14C]creatine uptake, which is blocked by low micromolar concentrations of recognized creatine uptake inhibitors. Two rCREAT mRNAs are expressed in the rat brain, retina, kidney and heart. Whole-brain rCREAT mRNAs demonstrate a marked postnatal rise to steady-state adult levels. In situ hybridization studies indicate a widespread, differential rCREAT mRNA expression in adult rat brain, with high expression noted over myelinated fiber tracts, cerebellar granule cells, hippocampal pyramidal cells, brainstem nuclei and endothelial cells of the choroid plexus. These studies will allow the development of new molecular probes useful for defining the creatine transporter's cellular expression pattern, function in ATP homeostasis and association with disorders of cellular energy metabolism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8940628     DOI: 10.1159/000111450

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  13 in total

Review 1.  Creatine and the creatine transporter: a review.

Authors:  R J Snow; R M Murphy
Journal:  Mol Cell Biochem       Date:  2001-08       Impact factor: 3.396

2.  Human, rat and chicken small intestinal Na+ - Cl- -creatine transporter: functional, molecular characterization and localization.

Authors:  M J Peral; M García-Delgado; M L Calonge; J M Durán; M C De La Horra; T Wallimann; O Speer; A Ilundáin
Journal:  J Physiol       Date:  2002-11-15       Impact factor: 5.182

Review 3.  X-linked creatine transporter deficiency: clinical aspects and pathophysiology.

Authors:  Jiddeke M van de Kamp; Grazia M Mancini; Gajja S Salomons
Journal:  J Inherit Metab Dis       Date:  2014-05-01       Impact factor: 4.982

4.  Effects of N-linked glycosylation on the creatine transporter.

Authors:  Nadine Straumann; Alexandra Wind; Tina Leuenberger; Theo Wallimann
Journal:  Biochem J       Date:  2006-01-15       Impact factor: 3.857

Review 5.  Pharmacokinetics of the dietary supplement creatine.

Authors:  Adam M Persky; Gayle A Brazeau; Günther Hochhaus
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

6.  Creatine transporters: a reappraisal.

Authors:  Oliver Speer; Lukas J Neukomm; Robyn M Murphy; Elsa Zanolla; Uwe Schlattner; Hugues Henry; Rodney J Snow; Theo Wallimann
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

7.  Creatine and pyruvate prevent the alterations caused by tyrosine on parameters of oxidative stress and enzyme activities of phosphoryltransfer network in cerebral cortex of Wistar rats.

Authors:  Rodrigo Binkowski de Andrade; Tanise Gemelli; Denise Bertin Rojas; Narielle Ferner Bonorino; Bruna May Lopes Costa; Cláudia Funchal; Carlos Severo Dutra-Filho; Clovis Milton Duval Wannmacher
Journal:  Mol Neurobiol       Date:  2014-06-25       Impact factor: 5.590

8.  Creatine supplementation in health and disease. Effects of chronic creatine ingestion in vivo: down-regulation of the expression of creatine transporter isoforms in skeletal muscle.

Authors:  M L Guerrero-Ontiveros; T Wallimann
Journal:  Mol Cell Biochem       Date:  1998-07       Impact factor: 3.396

Review 9.  AGAT, GAMT and SLC6A8 distribution in the central nervous system, in relation to creatine deficiency syndromes: a review.

Authors:  O Braissant; H Henry
Journal:  J Inherit Metab Dis       Date:  2008-04-04       Impact factor: 4.982

10.  Creatine and pyruvate prevent behavioral and oxidative stress alterations caused by hypertryptophanemia in rats.

Authors:  Vivian Strassburger Andrade; Denise Bertin Rojas; Lenise Oliveira; Mychely Lopes Nunes; Fernanda Luz de Castro; Cristina Garcia; Tanise Gemelli; Rodrigo Binkowski de Andrade; Clóvis Milton Duval Wannmacher
Journal:  Mol Cell Biochem       Date:  2011-11-12       Impact factor: 3.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.